Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives.
Focused suggestion with somatic anchoring technique: rapid self-hypnosis for pain management.
Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial.
Microbial colonization influences early B-lineage development in the gut lamina propria.
High levels of cerebrospinal fluid free kappa chains predict conversion to multiple sclerosis.
Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort.
Improved self-efficacy in persons with relapsing remitting multiple sclerosis after an intensive social cognitive wellness program with participation of support partners: a 6-months observational study.
Assessment of cerebral venous return by a novel plethysmography method.
Organic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysis.
Biologics at Novartis
PEGylated interferon beta-1a in the treatment of multiple sclerosis - an update.
Placebo? no thanks, it might be bad for me!
Posterior reversible encephalopathy syndrome masquerading as progressive multifocal leukoencephalopathy in rituximab treated neuromyelitis optica.
The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis.
DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP).
Noninvasive molecular imaging of neuroinflammation.
Effect of natalizumab treatment on circulating plasmacytoid dendritic cells: a cross-sectional observational study in patients with multiple sclerosis.
Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination.
Therapeutic effect of ghrelin in experimental autoimmune encephalomyelitis by inhibiting antigen-specific Th1/Th17 responses and inducing regulatory T cells.
The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study.
Effects of Gadolinium Contrast Agent Administration on Automatic Brain Tissue Classification of Patients with Multiple Sclerosis.
Vitamin A and systemic inflammation as protective factors in multiple sclerosis.
Exercise and quality of life in women with multiple sclerosis.
Multiple sclerosis and oligodendroglioma: an exceptional association.
Dried Blood Spot Methodology in Combination With Liquid Chromatography/Tandem Mass Spectrometry Facilitates the Monitoring of Teriflunomide.

Pages